Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05158205 · ClinicalTrials.gov registry record · NA

Yoga in Altering Mechanistic Outcomes in Hypertension

A NA study, sponsored by Texas State University.

Terminated
Registry status
NA
Development phase
30
Enrollment target

NCT05158205: Clinical Trial NA study, sponsored by Texas State University.

NCT05158205 is a NA study that was terminated before completion, run by Texas State University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05158205, a NA study, was terminated before completion, sponsored by Texas State University.

TERMINATED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The proposed study will assess the effects of yoga postures and slow, deep breathing in altering oxidative stress, vascular function, and blood pressure.

Primary Outcome

Blood draws will be performed at baseline and at weeks 4, 8, and 12 during the study after randomization and analyzed for free radicals after white blood cells are separated from whole blood.

Interventions

  • BEHAVIORAL Yoga
  • BEHAVIORAL Slow, deep breathing
  • BEHAVIORAL Control breathing

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-07-11
Est. Completion 2024-11-30
Phase NA
Texas State University

10 total trials

Why NCT05158205 stopped before completion

NCT05158205 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 3 interventions - of which Yoga is the first listed.

NCT05158205 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05158205 about?

NCT05158205 is a clinical study titled "Yoga in Altering Mechanistic Outcomes in Hypertension". The proposed study will assess the effects of yoga postures and slow, deep breathing in altering oxidative stress, vascular function, and blood pressure.

What is the current status of trial NCT05158205?

This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2022-07-11. Estimated completion is 2024-11-30.

What interventions are being tested in trial NCT05158205?

The interventions under investigation include: Yoga (BEHAVIORAL), Slow, deep breathing (BEHAVIORAL), Control breathing (BEHAVIORAL).

Who is sponsoring clinical trial NCT05158205?

This trial is sponsored by Texas State University, which has 10 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05158205's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05158205, the US trial registry maintained by the National Library of Medicine. NCT05158205 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.